Recombinant Viruses for Cancer Therapy

 Recombinant viruses area unit novel therapeutic agents that may be utilized for treatment of assorted diseases, as well as cancers. Recombinant viruses will be designed to precise foreign transgenes and have a broad reaction permitting organic phenomenon in an exceedingly wide selection of host cells. They can be designed for specific therapeutic goals. The recombinant viruses can be customizes to stimulate host response against tumor-specific antigens so that it can overcome the ability of the tumor to evade the host’s immune surveillance. Alternatively, recombinant viruses might categorical immunomodulatory genes that stimulate associate anti-cancer immune reaction

    Related Conference of Recombinant Viruses for Cancer Therapy

    October 30-30, 2021

    2nd International Conference on Hepatitis

    London, UK
    November 23-24, 2021

    World Conference on Digestive and metabolic diseases

    Hanoi, Vietnam
    December 02-03, 2021

    4th World Liver Congress

    Amsterdam, Netherlands
    February 21-22, 2022

    17th Euro-Global Gastroenterology Conference

    Berlin, Germany
    June 13-14, 2022

    28th World Conference on Gastroenterology & Hepatology

    Amsterdam, Netherlands
    July 18-19, 2022

    International Conference on Gastroenterology and Liver

    Amsterdam, Netherlands
    July 20-21, 2022

    21th World Gastroenterologists Summit

    Osaka, Japan

    Recombinant Viruses for Cancer Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in